Delivery Order SPE2DB20D9103-SPE2DB23FE7B4
Award Date
1/12/23
Potential Completion Date
1/13/23
Potential Value
$562
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a delivery order contract valued at two thousand eight hundred seven dollars and sixty cents ($2,807.60) to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The firm fixed price order is for the delivery of four thousand five hundred fifty-nine (4,559) Boostrix Tdap vaccine syringes in 0.5mL quantities by January 13, 2023 in support of the agency's stockpile of essential medical supplies. No set-aside designation was applied to this procurement. DMS...
DMS Pharmaceutical Group Inc. was awarded a five hundred thirty dollar delivery order against an unspecified contract vehicle to supply four hundred fifty-five thousand nine hundred fifty-seven doses of Boostrix TDAP vaccine in 0.5mL syringes to the Defense Logistics Agency by January 11, 2023. The firm fixed price order was awarded on January 10, 2023 without a set-aside designation. Performance will occur in Park Ridge, Illinois. The Boostrix TDAP vaccine syringes will support the Defense...
The Defense Logistics Agency awarded a $7,580.52 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois on January 10, 2023 for 4559587191 BOOSTRIX TDAP vaccine syringes in the quantity of 0.5mL each. The order is for delivery by January 11, 2023. No set-aside provisions were applied to this award placed under an existing DLA pharmaceuticals contract vehicle. DMS Pharmaceutical Group Inc. will fulfill the order from its Park Ridge facility to supply the tetanus,...
This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for $2,807.60 worth of Boostrix Tdap vaccine syringes to be delivered to a location in Park Ridge, Illinois. The completion date is January 12, 2023. The contract was awarded on January 11, 2023 under a firm fixed price arrangement. No set-aside designation was used for this order. The Defense Logistics Agency manages the global supply chain for the United States military and supports procurement...
The Defense Logistics Agency awarded a delivery order under an unspecified contract vehicle to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The firm fixed price order, valued at five hundred fifty-two dollars, is for the delivery of 4559609868 units of BOOSTRIX TDAP vaccine vials in 0.5mL quantities. Performance will occur in Park Ridge, Illinois by January 11, 2023. No set aside designation was applied to this order for the vaccines. As the DLA supports military readiness through...
This is a $28,696.68 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the BOOSTRIX TDAP vaccine syringe, 0.5 mL, with a completion date of June 14, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $6,815.90 firm fixed-price contract is for the procurement of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a pharmaceutical product, with a period of performance ending on January 17, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the...
The Defense Logistics Agency Troop Support Medical (DLA) awarded a $276,400 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 4561543977 doses of Boostrix TDAP vaccine in 0.5mL vials. The place of performance is Park Ridge, Illinois, with deliveries required between July 13-14, 2023. DLA manages the procurement and distribution of medical supplies and equipment for all branches of the U.S. Armed Forces. This delivery order was issued against an existing DLA medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,566,195,547 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML product, with a ceiling value of $4,782.78. The contract is a firm fixed-price delivery order with an ultimate completion date of October 23, 2024. DMS Pharmaceutical Group Inc. holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,807.60 firm fixed-price contract is for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue...